Silver Ronald's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed Mar 2, 2022
- Accession no.
- 0001209191-22-014661
- Filed
- Mar 2, 2022
- Trade date
- Feb 28, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $24.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Silver RonaldCIK 0001873731 | Officer (Principal Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Class A Common Stock | SSaleDisposed | −448 | $10.77 | −$4,824.96 | 63,001 | Direct | |
| Feb 28, 2022 | Class A Common Stock | SSaleDisposed | −640 | $10.77 | −$6,892.8 | 62,361 | Direct | |
| Feb 28, 2022 | Class A Common Stock | SSaleDisposed | −1,150 | $10.77 | −$12,385.5 | 61,211 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.